Aging and interstitial lung diseases: Unraveling an old forgotten player in the pathogenesis of lung fibrosis

Seminars in Respiratory and Critical Care Medicine

Volumn 31, Issue 5, 2010, Pages 607-617

  Selman, Moisés ^a   Rojas, Mauricio ^b   Mora, Ana L ^b   Pardo, Annie ^c  

^a INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

aging; Idiopathic pulmonary fibrosis; interstitial lung disease; lung fibrosis

Indexed keywords

REACTIVE OXYGEN METABOLITE;

AGED; AGING; ATHLETE; AUTOIMMUNITY; BONE MARROW CELL; CELL DEATH; EPIGENETICS; EXTRACELLULAR MATRIX; FIBROSING ALVEOLITIS; HUMAN; IMMUNE RESPONSE; INTERSTITIAL LUNG DISEASE; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; TELOMERE;

AGED; AGED, 80 AND OVER; AGING; ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; LUNG; LUNG DISEASES, INTERSTITIAL; MIDDLE AGED;

EID: 77958147116     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0030-1265901     Document Type: Review

References (100)

1. Harman D. Aging: overview. Ann N Y Acad Sci 2001 928 1-21
2. Raghu G, Weycker D, Edelsberg J, Bradford W Z., Oster G. Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2006 174 810-816
3. Huang K, Rabold R, Schofield B, Mitzner W, Tankersley C G. Age-dependent changes of airway and lung parenchyma in C57BL/6J mice. J Appl Physiol 2007 102 200-206
4. Briscoe W A., Dubois A B. The relationship between airway resistance, airway conductance and lung volume in subjects of different age and body size. J Clin Invest 1958 37 1279-1285
5. Gibson G J., Pride N B., O'cain C, Quagliato R. Sex and age differences in pulmonary mechanics in normal nonsmoking subjects. J Appl Physiol 1976 41 20-25
6. de la Fuente M, Hernanz A, Guayerbas N, Alvarez P, Alvarado C. Changes with age in peritoneal macrophage functions. Implication of leukocytes in the oxidative stress of senescence. Cell Mol Biol (Noisy-le-grand) 2004 50 Online Pub OL683-690
7. Elder A C., Gelein R, Finkelstein J N., Cox C, Oberdörster G. Pulmonary inflammatory response to inhaled ultrafine particles is modified by age, ozone exposure, and bacterial toxin. Inhal Toxicol 2000 12 (Suppl 4) 227-246
8. Pawelec G, Larbi A. Immunity and ageing in man: annual review 2006/2007. Exp Gerontol 2008 43 34-38
9. Meyer K C., Rosenthal N S., Soergel P, Peterson K. Neutrophils and low-grade inflammation in the seemingly normal aging human lung. Mech Ageing Dev 1998 104 169-181
10. Plackett T P., Schilling E M., Faunce D E., Choudhry M A., Witte P L., Kovacs E J. Aging enhances lymphocyte cytokine defects after injury. FASEB J 2003 17 688-689
11. Xu J, Mora A L., LaVoy J, Brigham K L., Rojas M. Increased bleomycin-induced lung injury in mice deficient in the transcription factor T-bet. Am J Physiol Lung Cell Mol Physiol 2006 291 L658-L667
12. Mora A L., Woods C R., Garcia A et al. Lung infection with gamma-herpesvirus induces progressive pulmonary fibrosis in Th2-biased mice. Am J Physiol Lung Cell Mol Physiol 2005 289 L711-L721
13. Prasse A, Pechkovsky D V., Toews G B. et al. A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18. Am J Respir Crit Care Med 2006 173 781-792
14. Murray L A., Argentieri R L., Farrell F X. et al. Hyper-responsiveness of IPF/UIP fibroblasts: interplay between TGFbeta1, IL-13 and CCL2. Int J Biochem Cell Biol 2008 40 2174-2182
15. Jones D P. Radical-free biology of oxidative stress. Am J Physiol Cell Physiol 2008 295 C849-C868
16. Jones D P. Extracellular redox state: refining the definition of oxidative stress in aging. Rejuvenation Res 2006 9 169-181
17. Kregel K C., Zhang H J. An integrated view of oxidative stress in aging: basic mechanisms, functional effects, and pathological considerations. Am J Physiol Regul Integr Comp Physiol 2007 292 R18-R36
18. Moriarty-Craige S E., Adkison J, Lynn M et al. Antioxidant supplements prevent oxidation of cysteine/cystine redox in patients with age-related macular degeneration. Am J Ophthalmol 2005 140 1020-1026
19. Iyer S S., Accardi C J., Ziegler T R. et al. Cysteine redox potential determines pro-inflammatory IL-1beta levels. PLoS One 2009 4 e5017
20. Ramirez A, Ramadan B, Ritzenthaler J D., Rivera H N., Jones D P., Roman J. Extracellular cysteine/cystine redox potential controls lung fibroblast proliferation and matrix expression through upregulation of transforming growth factor-beta. Am J Physiol Lung Cell Mol Physiol 2007 293 L972-L981
21. Jonas C R., Gu L H., Nkabyo Y S. et al. Glutamine and KGF each regulate extracellular thiol/disulfide redox and enhance proliferation in Caco-2 cells. Am J Physiol Regul Integr Comp Physiol 2003 285 R1421-R1429
22. Iyer S S., Ramirez A M., Ritzenthaler J D. et al. Oxidation of extracellular cysteine/cystine redox state in bleomycin-induced lung fibrosis. Am J Physiol Lung Cell Mol Physiol 2009 296 L37-L45
23. Martindale J L., Holbrook N J. Cellular response to oxidative stress: signaling for suicide and survival. J Cell Physiol 2002 192 1-15
24. Morrison J P., Coleman M C., Aunan E S., Walsh S A., Spitz D R., Kregel K C. Aging reduces responsiveness to BSO- and heat stress-induced perturbations of glutathione and antioxidant enzymes. Am J Physiol Regul Integr Comp Physiol 2005 289 R1035-R1041
25. Li J, Holbrook N J. Common mechanisms for declines in oxidative stress tolerance and proliferation with aging. Free Radic Biol Med 2003 35 292-299
26. Zhang H J., Xu L, Drake V J., Xie L, Oberley L W., Kregel K C. Heat-induced liver injury in old rats is associated with exaggerated oxidative stress and altered transcription factor activation. FASEB J 2003 17 2293-2295
27. Zhang H J., Doctrow S R., Xu L et al. Redox modulation of the liver with chronic antioxidant enzyme mimetic treatment prevents age-related oxidative damage associated with environmental stress. FASEB J 2004 18 1547-1549
28. Hussain S G., Ramaiah K V. Reduced eIF2alpha phosphorylation and increased proapoptotic proteins in aging. Biochem Biophys Res Commun 2007 355 365-370
29. Naidoo N. The endoplasmic reticulum stress response and aging. Rev Neurosci 2009 20 23-37
30. Wang X Z., Lawson B, Brewer J W. et al. Signals from the stressed endoplasmic reticulum induce C/EBP-homologous protein (CHOP/GADD153). Mol Cell Biol 1996 16 4273-4280
31. Ikeyama S, Wang X T., Li J et al. Expression of the pro-apoptotic gene gadd153/chop is elevated in liver with aging and sensitizes cells to oxidant injury. J Biol Chem 2003 278 16726-16731
32. Lawson W E., Crossno P F., Polosukhin V V. et al. Endoplasmic reticulum stress in alveolar epithelial cells is prominent in IPF: association with altered surfactant protein processing and herpesvirus infection. Am J Physiol Lung Cell Mol Physiol 2008 294 L1119-L1126
33. Korfei M, Ruppert C, Mahavadi P et al. Epithelial endoplasmic reticulum stress and apoptosis in sporadic idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2008 178 838-846
34. Ulianich L, Garbi C, Treglia A S. et al. ER stress is associated with dedifferentiation and an epithelial-to-mesenchymal transition-like phenotype in PC Cl3 thyroid cells. J Cell Sci 2008 121 (Pt 4) 477-486
35. Cuervo A M. Autophagy and aging: keeping that old broom working. Trends Genet 2008 24 604-612
36. Cuervo A M., Bergamini E, Brunk U T., Dröge W, Ffrench M, Terman A. Autophagy and aging: the importance of maintaining clean cells. Autophagy 2005 1 131-140
37. Levine B, Kroemer G. Autophagy in aging, disease and death: the true identity of a cell death impostor. Cell Death Differ 2009 16 1-2
38. Hornsby P J. Telomerase and the aging process. Exp Gerontol 2007 42 575-581
39. Tsakiri K D., Cronkhite J T., Kuan P J. et al. Adult-onset pulmonary fibrosis caused by mutations in telomerase. Proc Natl Acad Sci U S A 2007 104 7552-7557
40. Alder J K., Chen J J., Lancaster L et al. Short telomeres are a risk factor for idiopathic pulmonary fibrosis. Proc Natl Acad Sci U S A 2008 105 13051-13056
41. Mora A L., Rojas M. Aging and lung injury repair: a role for bone marrow derived mesenchymal stem cells. J Cell Biochem 2008 105 641-647
42. Conboy I M., Conboy M J., Wagers A J., Girma E R., Weissman I L., Rando T A. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 2005 433 760-764
43. Rojas M, Xu J, Woods C R. et al. Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol 2005 33 145-152
44. Xu J, Torres E, Mora A L. et al. Attenuation of obliterative bronchiolitis by a CXCR4 antagonist in the murine heterotopic tracheal transplant model. J Heart Lung Transplant 2008 27 1302-1310
45. Phillips R J., Burdick M D., Hong K et al. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest 2004 114 438-446
46. Hashimoto N, Jin H, Liu T, Chensue S W., Phan S H. Bone marrow-derived progenitor cells in pulmonary fibrosis. J Clin Invest 2004 113 243-252
47. Xu J, Mora A, Shim H, Stecenko A, Brigham K L., Rojas M. Role of the SDF-1/CXCR4 axis in the pathogenesis of lung injury and fibrosis. Am J Respir Cell Mol Biol 2007 37 291-299
48. Andersson-Sjöland A, de Alba C G., Nihlberg K et al. Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis. Int J Biochem Cell Biol 2008 40 2129-2140
49. Moeller A, Gilpin S E., Ask K et al. Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2009 179 588-594
50. Xu J, Gonzalez E T., Iyer S S. et al. Use of senescence-accelerated mouse model in bleomycin-induced lung injury suggests that bone marrow-derived cells can alter the outcome of lung injury in aged mice. J Gerontol A Biol Sci Med Sci 2009 64 731-739
51. Swiderski R E., Dencoff J E., Floerchinger C S., Shapiro S D., Hunninghake G W. Differential expression of extracellular matrix remodeling genes in a murine model of bleomycin-induced pulmonary fibrosis. Am J Pathol 1998 152 821-828
52. Kim K K., Kugler M C., Wolters P J. et al. Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc Natl Acad Sci U S A 2006 103 13180-13185
53. Magnuson V L., Young M, Schattenberg D G. et al. The alternative splicing of fibronectin pre-mRNA is altered during aging and in response to growth factors. J Biol Chem 1991 266 14654-14662
54. Muro A F., Moretti F A., Moore B B. et al. An essential role for fibronectin extra type III domain A in pulmonary fibrosis. Am J Respir Crit Care Med 2008 177 638-645
55. Adamson I Y., Bowden D H. The pathogenesis of bloemycin-induced pulmonary fibrosis in mice. Am J Pathol 1974 77 185-197
56. McMillan T R., Moore B B., Weinberg J B. et al. Exacerbation of established pulmonary fibrosis in a murine model by gammaherpesvirus. Am J Respir Crit Care Med 2008 177 771-780
57. Sime P J., Xing Z, Graham F L., Csaky K G., Gauldie J. Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung. J Clin Invest 1997 100 768-776
58. Uejima Y, Fukuchi Y, Nagase T, Tabata R, Orimo H. A new murine model of aging lung: the senescence accelerated mouse (SAM)-P. Mech Ageing Dev 1991 61 223-236
59. Selman M, King T E., Pardo A, American Thoracic Society European Respiratory Society American College of Chest Physicians. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 2001 134 136-151
60. Gross T J., Hunninghake G W. Idiopathic pulmonary fibrosis. N Engl J Med 2001 345 517-525
61. Noth I, Martinez F J. Recent advances in idiopathic pulmonary fibrosis. Chest 2007 132 637-650
62. Gotway M B., Freemer M M., King T E. Jr. Challenges in pulmonary fibrosis. 1: Use of high resolution CT scanning of the lung for the evaluation of patients with idiopathic interstitial pneumonias. Thorax 2007 62 546-553
63. Katzenstein A L., Mukhopadhyay S, Myers J L. Diagnosis of usual interstitial pneumonia and distinction from other fibrosing interstitial lung diseases. Hum Pathol 2008 39 1275-1294
64. King T E. Jr, Tooze J A., Schwarz M I., Brown K R., Cherniack R M. Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med 2001 164 1171-1181
65. von Figura G, Hartmann D, Song Z, Rudolph K L. Role of telomere dysfunction in aging and its detection by biomarkers. J Mol Med 2009 87 1165-1171
66. Armanios M. Syndromes of telomere shortening. Annu Rev Genomics Hum Genet 2009 10 45-61
67. Oeseburg H, de Boer R A., van Gilst W H., van der Harst P. Telomere biology in healthy aging and disease. Pflugers Arch 2010 459 259-268
68. Karlseder J, Smogorzewska A, de Lange T. Senescence induced by altered telomere state, not telomere loss. Science 2002 295 2446-2449
69. Armanios M Y., Chen J J., Cogan J D. et al. Telomerase mutations in families with idiopathic pulmonary fibrosis. N Engl J Med 2007 356 1317-1326
70. Cronkhite J T., Xing C, Raghu G et al. Telomere shortening in familial and sporadic pulmonary fibrosis. Am J Respir Crit Care Med 2008 178 729-737
71. Barja G. Free radicals and aging. Trends Neurosci 2004 27 595-600
72. Kuwano K, Hagimoto N, Maeyama T et al. Mitochondria-mediated apoptosis of lung epithelial cells in idiopathic interstitial pneumonias. Lab Invest 2002 82 1695-1706
73. Bellocq A, Azoulay E, Marullo S et al. Reactive oxygen and nitrogen intermediates increase transforming growth factor-beta1 release from human epithelial alveolar cells through two different mechanisms. Am J Respir Cell Mol Biol 1999 21 128-136
74. Barcellos-Hoff M H., Dix T A. Redox-mediated activation of latent transforming growth factor-beta 1. Mol Endocrinol 1996 10 1077-1083
75. Ho D H., Burggren W W. Epigenetics and transgenerational transfer: a physiological perspective. J Exp Biol 2010 213 3-16
76. Gravina S, Vijg J. Epigenetic factors in aging and longevity. Pflugers Arch 2010 459 247-258
77. Sanders Y Y., Pardo A, Selman M et al. Thy-1 promoter hypermethylation: a novel epigenetic pathogenic mechanism in pulmonary fibrosis. Am J Respir Cell Mol Biol 2008 39 610-618
78. Coward W R., Watts K, Feghali-Bostwick C A., Knox A, Pang L. Defective histone acetylation is responsible for the diminished expression of cyclooxygenase 2 in idiopathic pulmonary fibrosis. Mol Cell Biol 2009 29 4325-4339
79. Prelog M. Aging of the immune system: a risk factor for autoimmunity? Autoimmun Rev 2006 5 136-139
80. Manestar-Blazi T, Volf M. The dynamic of senescent cells accumulation can explain the age-specific incidence of autoimmune diseases. Med Hypotheses 2009 73 667-669
81. Pawelec G, Hirokawa K, Fülöp T. Altered T cell signalling in ageing. Mech Ageing Dev 2001 122 1613-1637
82. Goronzy J J., Weyand C M. Aging, autoimmunity and arthritis: T-cell senescence and contraction of T-cell repertoire diversitycatalysts of autoimmunity and chronic inflammation. Arthritis Res Ther 2003 5 225-234
83. Liu Y, Chen Y, Richardson B. Decreased DNA methyltransferase levels contribute to abnormal gene expression in senescent CD4(+)CD28(-) T cells. Clin Immunol 2009 132 257-265
84. Hasler P, Zouali M. Immune receptor signaling, aging, and autoimmunity. Cell Immunol 2005 233 102-108
85. Grolleau-Julius A, Ray D, Yung R L. The role of epigenetics in aging and autoimmunity. Clin Rev Allergy Immunol 2010 39 42-50
86. Rifas L, Arackal S. T cells regulate the expression of matrix metalloproteinase in human osteoblasts via a dual mitogen-activated protein kinase mechanism. Arthritis Rheum 2003 48 993-1001
87. Kim E J., Collard H R., King T E. Jr. Rheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic pattern. Chest 2009 136 1397-1405
88. Arnson Y, Shoenfeld Y, Amital H. Effects of tobacco smoke on immunity, inflammation and autoimmunity. J Autoimmun 2010 34 J258-265
89. Alamanos Y, Drosos A A. Epidemiology of adult rheumatoid arthritis. Autoimmun Rev 2005 4 130-136
90. Doran M F., Pond G R., Crowson C S., O'Fallon W M., Gabriel S E. Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period. Arthritis Rheum 2002 46 625-631
91. Koetz K, Bryl E, Spickschen K, O'Fallon W M., Goronzy J J., Weyand C M. T cell homeostasis in patients with rheumatoid arthritis. Proc Natl Acad Sci U S A 2000 97 9203-9208
92. Thewissen M, Linsen L, Somers V, Geusens P, Raus J, Stinissen P. Premature immunosenescence in rheumatoid arthritis and multiple sclerosis patients. Ann N Y Acad Sci 2005 1051 255-262
93. Weyand C M., Fujii H, Shao L, Goronzy J J. Rejuvenating the immune system in rheumatoid arthritis. Nat Rev Rheumatol 2009 5 583-588
94. Fujii H, Shao L, Colmegna I, Goronzy J J., Weyand C M. Telomerase insufficiency in rheumatoid arthritis. Proc Natl Acad Sci U S A 2009 106 4360-4365
95. Wagner U G., Koetz K, Weyand C M., Goronzy J J. Perturbation of the T cell repertoire in rheumatoid arthritis. Proc Natl Acad Sci U S A 1998 95 14447-14452
96. Tarjanyi O, Boldizsar F, Nemeth P, Mikecz K, Glant T T. Age-related changes in arthritis susceptibility and severity in a murine model of rheumatoid arthritis. Immun Ageing 2009 6 8
97. Kuro-o M. Disease model: human aging. Trends Mol Med 2001 7 179-181
98. Kuro-o M, Matsumura Y, Aizawa H et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 1997 390 45-51
99. Kuro-o M. Klotho. Pflugers Arch 2010 459 333-343
100. Witkowski J M., Soroczyska-Cybula M, Bryl E, Smoleska Z, Jówik A. Klotho a common link in physiological and rheumatoid arthritis-related aging of human CD4+lymphocytes. J Immunol 2007 178 771-777